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In June 2018, the World Health Organization (WHO) released 
a pre-final version of the 11th revision of the International Clas-
sification of Diseases and Related Health Problems (ICD-11) for 
mortality and morbidity statistics to its 194 member states, for 
review and preparation for implementation1. The World Health 
Assembly, comprising the ministers of health of all member 
states, is expected to approve the ICD-11 at its next meeting, 
in May 2019. Following approval, member states will begin a 
pro cess of transitioning from the ICD-10 to the ICD-11, with re-
porting of health statistics to the WHO using the ICD-11 to begin 
on January 1, 20222.
The WHO Department of Mental Health and Substance 
Abuse has been responsible for coordinating the development 
of four ICD-11 chapters: mental, behavioural and neurodeve l-
opmental disorders; sleep-wake disorders; diseases of the nerv-
ous system; and conditions related to sexual health (jointly with 
the WHO Department of Reproductive Health and Re search).
The mental disorders chapter of the ICD-10, the current 
version of the ICD, is by far the most widely used classification 
of mental disorders around the world3. During the develop-
ment of the ICD-10, the WHO Department of Mental Health 
and Substance Abuse considered that different versions of the 
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classification had to be produced in order to meet the needs of 
its various users. The version of the ICD-10 for statistical report-
ing contains short glossary-like definitions for each disorder 
category, but this was considered to be insufficient for use by 
mental health professionals in clinical settings4.
For mental health professionals, the Department developed 
the Clinical Descriptions and Diagnostic Guidelines (CDDG) for 
ICD-10 Mental and Behavioural Disorders4, informally known 
as the “blue book” , intended for general clinical, educational 
and service use. For each disorder, a description of the main 
clinical and associated features was provided, followed by more 
operationalized diagnostic guidelines that were designed to as-
sist mental health clinicians in making a confident diagnosis. 
Information from a recent survey5 suggests that clinicians regu-
larly use the material in the CDDG and often review it systemati-
cally when making an initial diagnosis, which is counter to the 
widespread belief that clinicians only use the classification for 
the purpose of obtaining diagnostic codes for administrative 
and billing purposes. The Department will publish an equiva-
lent CDDG version of ICD-11 as soon as possible following 
approval of the overall system by the World Health Assembly.
More than a decade of intensive work has gone into the de-
velopment of the ICD-11 CDDG. It has involved hundreds of 
content experts as members of Advisory and Working Groups 
and as consultants, as well as an extensive collaboration with 
WHO member states, funding agencies, and professional and 
scientific societies. The development of the ICD-11 CDDG has 
been the most global, multilingual, multidisciplinary and par-
ticipative revision process ever implemented for a classification 
of mental disorders.
GENERATING THE ICD-11 CDDG: PROCESS 
AND PRIORITIES
We have previously described the importance of clinical 
utility as an organizing principle in developing the ICD-11 
CDDG6,7. Health classifications represent the interface be-
tween health encounters and health information. A system that 
does not provide clinically useful information at the level of the 
health encounter will not be faithfully implemented by clini-
cians and therefore cannot provide a valid basis for summary 
health encounter data used for decision making at the health 
system, national and global level.
Clinical utility was, therefore, strongly emphasized in the 
in structions provided to a series of Working Groups, gener-
ally or ganized by disorder grouping, appointed by the WHO 
Department of Mental Health and Substance Abuse to make 
recommendations regarding the structure and content of the 
ICD-11 CDDG.
Of course, in addition to being clinically useful and globally 
applicable, the ICD-11 must be scientifically valid. Accordingly, 
Working Groups were also asked to review the available scien-
tific evidence relevant to their areas of work as a basis for de-
veloping their proposals for ICD-11.
The importance of global applicability6 was also strongly 
emphasized to Working Groups. All groups included repre-
sentatives from all WHO global regions – Africa, the Americas, 
Europe, Eastern Mediterranean, Southeast Asia, and Western 
Pacific – and a substantial proportion of individuals from low- 
and middle-income countries, which account for more than 
80% of the world’s population8.
A shortcoming of the ICD-10 CDDG was the lack of consist-
ency in the material provided across disorder groupings9. For 
the ICD-11 CDDG, Working Groups were asked to deliver their 
recommendations as “content forms” , including consistent and 
systematic information for each disorder that provided the ba-
sis for the diagnostic guidelines.
We have previously published a detailed description of the 
work process and the structure of the ICD-11 diagnostic guide-
lines9. The development of the ICD-11 CDDG occurred during 
a period that overlapped substantially with the production of 
the DSM-5 by the American Psychiatric Association, and many 
ICD-11 Working Groups included overlapping membership 
with corresponding groups working on the DSM-5. ICD-11 
Working Groups were asked to consider the clinical utility and 
global applicability of material being developed for the DSM-5. 
A goal was to minimize random or arbitrary differences be-
tween the ICD-11 and the DSM-5, although justified concep-
tual differences were permitted.
INNOVATIONS IN THE ICD-11 CDDG
A particularly important feature of the ICD-11 CDDG is their 
approach to describing the essential features of each disor-
der, which represent those symptoms or characteristics that 
a clinician could reasonably expect to find in all cases of the 
disorder. While the lists of essential features in the guidelines 
superficially resemble diagnostic criteria, arbitrary cutoffs and 
precise requirements related to symptom counts and dura-
tion are generally avoided, unless these have been empirically 
established across countries and cultures or there is another 
compelling reason to include them.
This approach is intended to conform to the way clinicians 
actually make diagnoses, with the flexible exercise of clinical 
judgment, and to increase clinical utility by allowing for cultural 
variations in presentation as well as contextual and health-sys-
tem factors that may affect diagnostic practice. This flexible ap-
proach is consistent with results of surveys of psychiatrists and 
psychologists undertaken early in the ICD-11 development pro-
cess regarding the desirable characteristics of a mental disor-
ders classification system3,10. Field studies in clinical settings in 
13 countries have confirmed that clinicians consider the clinical 
utility of this approach to be high11. Importantly, the diagnostic 
reliability of the ICD-11 guidelines appears to be at least as high 
as that obtained using a strict criteria-based approach12.
A number of other innovations in the ICD-11 CDDG were 
also introduced by means of the template provided to Working 
Groups for making their recommendations (that is, the “con-
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tent form”). As a part of the standardization of information pro-
vided in the guidelines, attention was devoted for each disorder 
to the systematic characterization of the boundary with normal 
variation and to the expansion of the information provided on 
boundaries with other disorders (differential diagnosis).
The lifespan approach adopted for the ICD-11 meant that 
the separate grouping of behavioural and emotional disorders 
with onset usually occurring in childhood and adolescence was 
eliminated, and these disorders distributed to other groupings 
with which they share symptoms. For example, separation 
anxiety disorder was moved to the anxiety and fear-related dis-
orders grouping. Moreover, the ICD-11 CDDG provide informa-
tion for each disorder and/or grouping where data were avail-
able describing variations in the presentation of the disorder 
among children and adolescents as well as among older adults.
Culture-related information was systematically incorporated 
based on a review of the literature on cultural influences on 
psychopathology and its expression for each ICD-11 diagnostic 
grouping as well as a detailed review of culture-related material 
in the ICD-10 CDDG and the DSM-5. The cultural guidance for 
panic disorder is provided in Table 1 as an example.
Another major innovation in the ICD-11 classification has 
been the incorporation of dimensional approaches within the 
context of an explicitly categorical system with specific taxo-
nomic constraints. This effort was stimulated by the evidence 
that most mental disorders can be best described along a num-
ber of interacting symptom dimensions rather than as discrete 
categories13-15, and has been facilitated by innovations in the 
coding structure for the ICD-11. The dimensional potential of 
the ICD-11 is most clearly realized in the classification of per-
sonality disorders16,17.
For non-specialist settings, the dimensional rating of sever-
ity for ICD-11 personality disorders offers greater simplicity 
and clinical utility than the ICD-10 classification of specific 
personality disorders, improved differentiation of patients who 
need complex as compared to simpler treatments, and a better 
mechanism for tracking changes over time. In more special-
ized settings, the constellation of individual personality traits 
can inform specific intervention strategies. The dimensional 
system eliminates both the artificial comorbidity of personality 
disorders and the unspecified personality disorder diagnoses, 
as well as providing a basis for research into underlying dimen-
sions and interventions across various personality disorder man-
ifestations.
A set of dimensional qualifiers has also been introduced to 
describe the symptomatic manifestations of schizophrenia and 
other primary psychotic disorders18. Rather than focusing on 
diagnostic subtypes, the dimensional classification focuses on 
relevant aspects of the current clinical presentation in ways 
that are much more consistent with recovery-based psychiatric 
rehabilitation approaches.
The dimensional approaches to personality disorders and 
symptomatic manifestations of primary psychotic disorders 
are described in more detail in the respective sections later in 
this paper.
ICD-11 FIELD STUDIES
The ICD-11 field studies program also represents an area 
of major innovation. This program of work has included the 
use of novel methodologies for studying the clinical utility of 
the draft diagnostic guidelines, including their accuracy and 
consistency of application by clinicians as compared to ICD-10 
as well as the specific elements responsible for any observed 
confusion19. A key strength of the research program has been 
that most studies have been conducted in a time frame allow-
ing their results to provide a basis for revision of the guidelines 
to address any observed weaknesses20.
Global participation has also been a defining characteristic 
of the ICD-11 CDDG field studies program. The Global Clini-
cal Practice Network (GCPN) was established to allow mental 
health and primary care professionals from all over the world 
to participate directly in the development of the ICD-11 CDDG 
through Internet-based field studies.
Over time, the GCPN has expanded to include nearly 15,000 
clinicians from 155 countries. All WHO global regions are rep-
resented in proportions that largely track the availability of 
mental health professionals by region, with the largest propor-
tions coming from Asia, Europe and the Americas (approxi-
mately equally divided between the US and Canada on the one 
hand and Latin America on the other). More than half of GCPN 
Table 1 Cultural considerations for panic disorder
 • The symptom presentation of  panic attacks may vary across 
cultures, influenced by cultural attributions about their origin or 
pathophysiology. For example, individuals of  Cambodian origin 
may emphasize panic symptoms attributed to dysregulation of  
khyâl, a wind-like substance in traditional Cambodian ethnophys-
iology (e.g., dizziness, tinnitus, neck soreness).
 • There are several notable cultural concepts of  distress related to 
panic  disorder, which link panic, fear, or anxiety to etiological at-
tributions regarding specific social and environmental influences. 
Examples include attributions related to interpersonal conflict 
(e.g., ataque de nervios among Latin American people), exertion 
or orthostasis (khyâl cap among Cambodians), and atmospheric 
wind (trúng gió among Vietnamese  individuals). These cultural 
labels may be applied to  symptom  presentations other than panic 
(e.g., anger paroxysms, in the case of  ataque de nervios) but they 
often constitute panic episodes or presentations with partial 
phenomenological overlap with panic attacks.
 • Clarifying cultural attributions and the context of the experience of  
 symptoms can inform whether panic attacks should be considered 
expected or unexpected, as would be the case in panic disorder. For 
example, panic attacks may involve specific foci of apprehension 
that are better explained by another disorder (e.g., social situations 
in social anxiety disorder). Moreover, the cultural linkage of the 
apprehension focus with specific exposures (e.g., wind or cold and 
trúng gió panic attacks) may suggest that acute anxiety is expected 
when considered within the individual’s cultural framework.
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members are physicians, predominantly psychiatrists, and 30% 
are psychologists.
Approximately a dozen GCPN studies have been completed 
to date, most focusing on comparisons of the proposed ICD-
11 diagnostic guidelines with ICD-10 guidelines in terms of 
accuracy and consistency of clinicians’ diagnostic formula-
tions, using standardized case material manipulated to test 
key differences19,21. Other studies have examined scaling for 
diagnostic qualifiers22 and how clinicians actually use clas-
sifications5. GCPN studies have been conducted in Chinese, 
French, Japanese, Russian and Spanish, in addition to English, 
and have included an examination of results by region and 
language to identify potential difficulties in global or cultural 
applicability as well as problems in translation.
Clinic-based studies have also been conducted through a 
network of international field study centers to evaluate the 
clinical utility and usability of the proposed ICD-11 diagnostic 
guidelines in natural conditions, in the settings in which they 
are intended to be used11. These studies also evaluated the 
reliability of diagnoses that account for the greatest propor-
tion of disease burden and mental health services utilization12. 
International field studies were located in 14 countries across 
all WHO global regions, and patient interviews for the studies 
were conducted in the local language of each country.
OVERALL STRUCTURE OF THE ICD-11 
CHAPTER ON MENTAL, BEHAVIOURAL AND 
NEURODEVELOPMENTAL DISORDERS
In the ICD-10, the number of groupings of disorders was ar-
tificially constrained by the decimal coding system used in the 
classification, such that it was only possible to have a maximum 
of ten major groupings of disorders within the chapter on men-
tal and behavioural disorders. As a result, diagnostic groupings 
were created that were not based on clinical utility or scientific 
evidence (e.g., anxiety disorders being included as part of the 
heterogeneous grouping of neurotic, stress-related, and soma-
toform disorders). ICD-11’s use of a flexible alphanumeric cod-
ing structure allowed for a much larger number of groupings, 
making it possible to develop diagnostic groupings based more 
closely on scientific evidence and the needs of clinical practice.
In order to provide data to assist in developing an organi-
zational structure that would be more clinically useful, two 
formative field studies were conducted23,24 to examine the con-
ceptualizations held by mental health professionals around 
the world regarding the relationships among mental disorders. 
These data informed decisions about the optimal structure of 
the classification. The ICD-11 organizational structure was also 
influenced by efforts by the WHO and the American Psychiatric 
Association to harmonize the overall structure of the ICD-11 
chapter on mental and behavioural disorders with the structure 
of the DSM-5.
The organization of the ICD-10 chapter on mental and be-
havioural disorders largely reflected the chapter organization 
originally used in Kraepelin’s Textbook of Psychiatry, which 
began with organic disorders, followed by psychoses, neurotic 
dis orders, and personality disorders25. Principles guiding the 
ICD-11 organization included trying to order the diagnostic 
groupings following a developmental perspective (hence, neu-
rodevelopmental disorders appear first and neurocognitive 
disorders last in the classification) and grouping disorders to-
gether based on putative shared etiological and pathophysi-
ological factors (e.g., disorders specifically associated with 
stress) as well as shared phenomenology (e.g., dissociative 
disorders). Table 2 provides a listing of the diagnostic groupings 
in the ICD-11 chapter on mental, behavioural and neurodevel-
opmental disorders.
The classification of sleep disorders in the ICD-10 relied on 
the now obsolete separation between organic and non-organic 
disorders, resulting in the “non-organic” sleep disorders being 
included in the chapter on mental and behavioural disorders 
of the ICD-10, and the “organic” sleep disorders being included 
in other chapters (i.e., diseases of the nervous system, dis-
eases of the respiratory system, and endocrine, nutritional and 
metabolic disorders). In ICD-11, a separate chapter has been 
created for sleep-wake disorders that encompasses all relevant 
sleep-related diagnoses.
Table 2 Disorder groupings in the ICD-11 chapter on mental, behav-
ioural and neurodevelopmental disorders
Neurodevelopmental disorders
Schizophrenia and other primary psychotic disorders
Catatonia
Mood disorders
Anxiety and fear-related disorders
Obsessive-compulsive and related disorders
Disorders specifically associated with stress
Dissociative disorders
Feeding and eating disorders
Elimination disorders
Disorders of  bodily distress and bodily experience
Disorders due to substance use and addictive behaviours
Impulse control disorders
Disruptive behaviour and dissocial disorders
Personality disorders
Paraphilic disorders
Factitious disorders
Neurocognitive disorders
Mental and behavioural disorders associated with pregnancy, childbirth and 
the puerperium
Psychological and behavioural factors affecting disorders or diseases 
 classified elsewhere
Secondary mental or behavioural syndromes associated with disorders or 
diseases classified elsewhere
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The ICD-10 also embodied a dichotomy between organic 
and non-organic in the realm of sexual dysfunctions, with “non-
organic” sexual dysfunctions included in the chapter on mental 
and behavioural disorders, and “organic” sexual dysfunctions 
for the most part listed in the chapter on diseases of the genitou-
rinary system. A new integrated chapter for conditions related to 
sexual health has been added to the ICD-11 to house a unified 
classification of sexual dysfunctions and sexual pain disorders26 
as well as changes in male and female anatomy. Moreover, ICD-
10 gender identity disorders have been renamed as “gender 
incongruence” in the ICD-11 and moved from the mental dis-
orders chapter to the new sexual health chapter26, meaning that 
a transgender identity is no longer to be considered a mental 
disorder. Gender incongruence is not proposed for elimination 
in the ICD-11 because in many countries access to relevant 
health services is contingent on a qualifying diagnosis. The ICD-
11 guidelines explicitly state that gender variant behaviour and 
preferences alone are not sufficient for making a diagnosis.
NEW MENTAL, BEHAVIOURAL AND 
NEURODEVELOPMENTAL DISORDERS IN THE 
ICD-11
Based on a review of the available evidence on scientific 
validity, and a consideration of clinical utility and global ap-
plicability, a number of new disorders have been added to the 
ICD-11 chapter on mental, behavioural and neurodevelop-
mental disorders. A description of these disorders as defined 
in the ICD-11 diagnostic guidelines and the rationale for their 
inclusion are provided below.
Catatonia
In the ICD-10, catatonia was included as one of the subtypes 
of schizophrenia (i.e., catatonic schizophrenia) and as one of 
the organic disorders (i.e., organic catatonic disorder). In rec-
ognition of the fact that the syndrome of catatonia can occur 
in association with a variety of mental disorders27, a new diag-
nostic grouping for catatonia (at the same hierarchical level as 
mood disorders, anxiety and fear-related disorders, etc.) has 
been added in the ICD-11.
Catatonia is characterized by the occurrence of several 
symptoms such as stupor, catalepsy, waxy flexibility, mutism, 
negativism, posturing, mannerisms, stereotypies, psychomotor 
agitation, grimacing, echolalia and echopraxia. Three condi-
tions are included in the new diagnostic grouping: a) catato-
nia associated with another mental disorder (such as a mood 
disorder, schizophrenia or other primary psychotic disorder, 
or autism spectrum disorder); b) catatonia induced by psycho-
active substances, including medications (e.g., antipsychotic 
medications, amphetamines, phencyclidine); and c) secondary 
catatonia (i.e., caused by a medical condition, such as diabetic 
ketoacidosis, hypercalcemia, hepatic encephalopathy, homo-
cystinuria, neoplasm, head trauma, cerebrovascular disease, 
or encephalitis).
Bipolar type II disorder
The DSM-IV introduced two types of bipolar disorder. Bi-
polar type I disorder applies to presentations characterized 
by at least one manic episode, whereas bipolar type II disor-
der re quires at least one hypomanic episode plus at least one 
major de pressive episode, in the absence of a history of manic 
episodes. Evidence supporting the validity of the distinction 
between these two types includes differences in antidepressant 
monotherapy response28, neurocognitive measures28,29, genetic 
effects28,30, and neuroimaging findings28,31,32.
Given this evidence, and the clinical utility of differentiating 
between these two types33, bipolar disorder in ICD-11 has also 
been subdivided into type I and type II bipolar disorder.
Body dysmorphic disorder
Individuals with body dysmorphic disorder are persistently 
preoccupied with one or more defects or flaws in their bodily 
appearance that are either unnoticeable or only slightly notice-
able to others34. The preoccupation is accompanied by repeti-
tive and excessive behaviours, including repeated examination 
of the appearance or severity of the perceived defect or flaw, ex-
cessive attempts to camouflage or alter the perceived defect, or 
marked avoidance of social situations or triggers that increase 
distress about the perceived defect or flaw.
Originally called “dysmorphophobia” , this condition was 
first included in the DSM-III-R. It appeared in the ICD-10 as 
an embedded but incongruous inclusion term under hypo-
chondriasis, but clinicians were instructed to diagnose it as 
delusional disorder in cases in which associated beliefs were 
considered delusional. This created a potential for the same 
disorder to be assigned different diagnoses without recognizing 
the full spectrum of severity of the disorder, which can include 
beliefs that appear delusional due to the degree of conviction 
or fixity with which they are held.
In recognition of its distinct symptomatology, prevalence in 
the general population and similarities to obsessive-compul-
sive and related disorders (OCRD), body dysmorphic disorder 
has been included in this latter grouping in the ICD-1135.
Olfactory reference disorder
This condition is characterized by a persistent preoccupation 
with the belief that one is emitting a perceived foul or offensive 
body odour or breath, that is either unnoticeable or only slightly 
noticeable to others34.
In response to their preoccupation, individuals engage in 
repetitive and excessive behaviours such as repeatedly checking 
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for body odour or checking the perceived source of the smell; 
repeatedly seeking reassurance; excessive attempts to camou-
flage, alter or prevent the perceived odour; or marked avoidance 
of social situations or triggers that increase distress about the 
perceived foul or offensive odour. Affected individuals typically 
fear or are convinced that others noticing the smell will reject 
or humiliate them36.
Olfactory reference disorder is included in the ICD-11 OCRD 
grouping, as it shares phenomenological similarities with other 
disorders in this grouping with respect to the presence of per-
sistent intrusive preoccupations and associated repetitive be-
haviours35.
Hoarding disorder
Hoarding disorder is characterized by the accumulation of 
possessions, due to their excessive acquisition or to difficulty 
discarding them, regardless of their actual value35,37. Excessive 
acquisition is characterized by repetitive urges or behaviours 
related to amassing or buying items. Difficulty discarding is 
characterized by a perceived need to save items and a distress 
associated with discarding them. The accumulation of posses-
sions results in living spaces becoming cluttered to the point 
that their use or safety is compromised.
Although hoarding behaviours may be exhibited as a part of 
a broad range of mental and behavioural disorders and other 
conditions – including obsessive-compulsive disorder, depres-
sive disorders, schizophrenia, dementia, autism spectrum dis-
orders and Prader-Willi syndrome – there is sufficient evidence 
supporting hoarding disorder as a separate and unique disor-
der38.
Individuals affected by hoarding disorder are underrecog-
nized and undertreated, which argues from a public health per-
spective for its inclusion in the ICD-1139.
Excoriation disorder
A new diagnostic subgrouping, body-focused repetitive be-
haviour disorders, has been added to the OCRD grouping. It 
includes trichotillomania (which was included in the grouping 
of habit and impulse disorders in ICD-10) and a new condition, 
excoriation disorder (also known as skin-picking disorder).
Excoriation disorder is characterized by recurrent picking of 
one’s own skin, leading to skin lesions, accompanied by unsuc-
cessful attempts to decrease or stop the behaviour. The skin 
picking must be severe enough to result in significant distress 
or impairment in functioning. Excoriation disorder (and tricho-
tillomania) are distinct from other OCRDs in that the behaviour 
is rarely preceded by cognitive phenomena such as intrusive 
thoughts, obsessions or preoccupations, but instead may be 
preceded by sensory experiences.
Their inclusion in the OCRD grouping is based on shared 
phenomenology, patterns of familial aggregation, and puta tive 
etiological mechanisms with other disorders in this group-
ing35,40.
Complex post-traumatic stress disorder
Complex post-traumatic stress disorder (complex PTSD)41 
most typically follows severe stressors of a prolonged nature, 
or multiple or repeated adverse events from which escape is 
difficult or impossible, such as torture, slavery, genocide cam-
paigns, prolonged domestic violence, or repeated childhood 
sexual or physical abuse.
The symptom profile is marked by the three core fea tures of 
PTSD (i.e., re-experiencing the traumatic event or events in the 
present in the form of vivid intrusive memories, flashbacks or 
nightmares; avoidance of thoughts and memories of the event or 
activities, situations or people reminiscent of the event; per sist-
ent perceptions of heightened current threat), which are ac com-
panied by additional persistent, pervasive and enduring distur-
banc es in affect regulation, self-concept and relational functioning.
The addition of complex PTSD to the ICD-11 is justified on 
the basis of the evidence that individuals with the disorder 
have a poorer prognosis and benefit from different treatments 
as compared to individuals with PTSD42. Complex PTSD re-
places the overlapping ICD-10 category of enduring personality 
change after catastrophic experience41.
Prolonged grief disorder
Prolonged grief disorder describes abnormally persistent 
and disabling responses to bereavement41. Following the death 
of a partner, parent, child or other person close to the bereaved, 
there is a persistent and pervasive grief response character-
ized by longing for the deceased or persistent preoccupation 
with the deceased, accompanied by intense emotional pain. 
Symptoms may include sadness, guilt, anger, denial, blame, dif-
ficulty accepting the death, feeling that the individual has lost 
a part of one’s self, an inability to experience positive mood, 
emotional numbness, and difficulty in engaging with social or 
other activities. The grief response must persist for an atypically 
long period of time following the loss (more than six months) 
and clearly exceed expected social, cultural or religious norms 
for the individual’s culture and context.
Although most people report at least partial remission from 
the pain of acute grief by around six months following bereave-
ment, those who continue experiencing severe grief reactions 
are more likely to experience significant impairment in their 
functioning. The inclusion of prolonged grief disorder in the 
ICD-11 is a response to the increasing evidence of a distinct 
and debilitating condition that is not adequately described by 
current ICD-10 diagnoses43. Its inclusion and differentiation 
from culturally normative bereavement and depressive episode 
is important, because of the different treatment selection impli-
cations and prognoses of these latter disorders44.
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Binge eating disorder
Binge eating disorder is characterized by frequent, recurrent 
episodes of binge eating (e.g., once a week or more over a period 
of several months). A binge eating episode is a distinct period 
of time during which the individual experiences a subjective 
loss of control over eating, eats notably more or differently than 
usual, and feels unable to stop eating or limit the type or amount 
of food eaten.
Binge eating is experienced as very distressing and is often 
accompanied by negative emotions such as guilt or disgust. 
However, unlike in bulimia nervosa, binge eating episodes 
are not regularly followed by inappropriate compensatory be-
haviours aimed at preventing weight gain (e.g., self-induced 
vomiting, misuse of laxatives or enemas, strenuous exercise). 
Although binge eating disorder is often associated with weight 
gain and obesity, these features are not a requirement and the 
disorder can be present in normal weight individuals.
The addition of binge eating disorder in the ICD-11 is based 
on extensive research that has emerged during the last 20 years 
supporting its validity and clinical utility45,46. Individuals who 
report episodes of binge eating without inappropriate compen-
satory behaviours represent the most common group among 
those who receive ICD-10 diagnoses of other specified or un-
specified eating disorder, so that it is expected that the inclu-
sion of binge eating disorder will reduce these diagnoses47.
Avoidant/restrictive food intake disorder
Avoidant/restrictive food intake disorder (ARFID) is char-
acterized by abnormal eating or feeding behaviours that result 
in the intake of an insufficient quantity or variety of food to 
meet adequate energy or nutritional requirements. This results 
in significant weight loss, failure to gain weight as expected 
in childhood or pregnancy, clinically significant nutritional 
deficiencies, dependence on oral nutritional supplements or 
tube feeding, or otherwise negatively affects the health of the 
individual or results in significant functional impairment.
ARFID is distinguished from anorexia nervosa by the ab-
sence of concerns about body weight or shape. Its inclu sion in 
the ICD-11 can be considered to be an expansion of the ICD-10 
category “feeding disorder of infancy and childhood”, and is 
likely to improve clinical utility across the lifespan (i.e., un-
like its ICD-10 counterpart, ARFID applies to children, ado-
lescents and adults) as well as maintaining consistency with 
DSM-545,47.
Body integrity dysphoria
Body integrity dysphoria is a rare disorder characterized by 
the persistent desire to have a specific physical disability (e.g., 
amputation, paraplegia, blindness, deafness) beginning in 
childhood or early adolescence48. The desire can be manifested 
in a number of ways, including fantasizing about having the 
desired physical disability, engaging in “pretending” behaviour 
(e.g., spending hours in a wheelchair or using leg braces to 
simulate having leg weakness), and spending time searching 
for ways to achieve the desired disability.
The preoccupation with the desire to have the physical dis-
ability (including time spent pretending) significantly interferes 
with productivity, leisure activities, or social functioning (e.g., 
the person is unwilling to have close relationships because it 
would make it difficult to pretend). Moreover, for a significant 
minority of individuals with this desire, their preoccupation 
goes beyond fantasy, and they pursue actualization of the desire 
through surgical means (i.e., by procuring an elective amputation 
of an otherwise healthy limb) or by self-damaging a limb to a 
degree in which amputation is the only therapeutic option (e.g., 
freezing a limb in dry ice).
Gaming disorder
As online gaming has greatly increased in popularity in re-
cent years, problems have been observed related to excessive 
involvement in gaming. Gaming disorder has been included 
in a newly added diagnostic grouping called “disorders due to 
addictive behaviours” (which also contains gambling disorder) 
in response to global concerns about the impact of problematic 
gaming, especially the online form49.
Gaming disorder is characterized by a pattern of persistent 
or recurrent Internet-based or offline gaming behaviour (“digit-
al gaming” or “video-gaming”) that is manifested by impaired 
control over the behaviour (e.g., inability to limit the amount 
of time spent gaming), giving increasing priority to gaming to 
the extent that it takes precedence over other life interests and 
daily activities; and continuing or escalating gaming despite its 
negative consequences (e.g., being repeatedly fired from jobs 
because of excessive absences due to gaming). It is differenti-
ated from non-pathological gaming behaviour by the clinically 
significant distress or impairment in functioning it produces.
Compulsive sexual behaviour disorder
Compulsive sexual behaviour disorder is characterized by 
a persistent pattern of failure to control intense repetitive sex-
ual impulses or urges, resulting in repetitive sexual behaviour 
over an extended period (e.g., six months or more) that causes 
marked distress or impairment in personal, family, social, edu-
cational, occupational or other important areas of functioning.
Possible manifestations of the persistent pattern include: 
repetitive sexual activities becoming a central focus of the indi-
vidual’s life to the point of neglecting health and personal care 
or other interests, activities and responsibilities; the individual 
making numerous unsuccessful efforts to control or significantly 
reduce the repetitive sexual behaviour; the individual continu-
ing to engage in repetitive sexual behaviour despite adverse 
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consequences such as repeated relationship disruption; and 
the individual continuing to engage in repetitive sexual behav-
iour even when he or she no longer derives any satisfaction 
from it.
Although this category phenomenologically resembles sub-
stance dependence, it is included in the ICD-11 impulse con-
trol disorders section in recognition of the lack of definitive 
information on whether the processes involved in the develop-
ment and maintenance of the disorder are equivalent to those 
observed in substance use disorders and behavioural addic-
tions. Its inclusion in the ICD-11 will help to address unmet 
needs of treatment seeking patients as well as possibly reducing 
shame and guilt associated with help seeking among distressed 
individuals50.
Intermittent explosive disorder
Intermittent explosive disorder is characterized by repeated 
brief episodes of verbal or physical aggression or destruction of 
property that represent a failure to control aggressive impulses, 
with the intensity of the outburst or degree of aggressiveness 
being grossly out of proportion to the provocation or precipitat-
ing psychosocial stressors.
Because such episodes can occur in a variety of other con-
ditions (e.g., oppositional defiant disorder, conduct disorder, 
bipolar disorder), the diagnosis is not given if the episodes are 
better explained by another mental, behavioural or neurode-
velopmental disorder.
Although intermittent explosive disorder was introduced in 
the DSM-III-R, it appeared in the ICD-10 only as an inclusion 
term under “other habit and impulse disorders” . It is included 
in the ICD-11 impulse control disorders section in recognition 
of the substantial evidence of its validity and utility in clinical 
settings51.
Premenstrual dysphoric disorder
Premenstrual dysphoric disorder (PMDD) is characterized 
by a variety of severe mood, somatic or cognitive symptoms 
that begin several days before the onset of menses, start to im-
prove within a few days, and become minimal or absent within 
approximately one week following the onset of menses.
More specifically, the diagnosis requires a pattern of mood 
symptoms (depressed mood, irritability), somatic symptoms 
(lethargy, joint pain, overeating), or cognitive symptoms (con-
centration difficulties, forgetfulness) that have occurred dur-
ing a majority of menstrual cycles within the past year. The 
symptoms are severe enough to cause significant distress or 
significant impairment in personal, family, social, educational, 
occupational or other important areas of functioning, and do 
not represent the exacerbation of another mental disorder.
In the ICD-11, PMDD is differentiated from the far more com-
mon premenstrual tension syndrome by the severity of the 
symptoms and the requirement that they cause significant dis-
tress or impairment52. The inclusion of PMDD in the research 
appendices of the DSM-III-R and DSM-IV stimulated a great 
deal of research that has established its validity and reliabil-
ity52,53, leading to its inclusion in both the ICD-11 and DSM-5. 
Although its primary location in the ICD-11 is in the chapter 
on diseases of the genitourinary system, PMDD is cross-listed in 
the subgrouping of depressive disorders due to the prominence 
of mood symptomatology.
SUMMARY OF CHANGES BY ICD-11 DISORDER 
GROUPING
The following sections summarize the changes introduced in 
each of the main disorder groupings of the ICD-11 chapter on 
mental, behavioural and neurodevelopmental disorders in ad-
dition to the new categories described in the previous section.
These changes have been made on the basis of a review of 
available scientific evidence by ICD-11 Working Groups and 
expert consultants, consideration of clinical utility and global 
applicability, and, where possible, the results of field testing.
Neurodevelopmental disorders
Neurodevelopmental disorders are those that involve sig-
nificant difficulties in the acquisition and execution of specific 
intellectual, motor, language or social functions with onset dur-
ing the developmental period. ICD-11 neurodevelopmental 
disorders encompass the ICD-10 groupings of mental retar-
dation and disorders of psychological development, with the 
addition of attention deficit hyperactivity disorder (ADHD).
Major changes in the ICD-11 include the renaming of disor-
ders of intellectual development from ICD-10 mental retarda-
tion, which was an obsolete and stigmatizing term that did not 
adequately capture the range of forms and etiologies associated 
with this condition54. Disorders of intellectual development 
continue to be defined on the basis of significant limitations in 
intellectual functioning and adaptive behaviour, ideally deter-
mined by standardized, appropriately normed and individually 
administered measures. In recognition of the lack of access to 
locally appropriate standardized measures or trained person-
nel to administer them in many parts of the world, and because 
of the importance of determining severity for treatment plan-
ning, the ICD-11 CDDG also provide a comprehensive set of 
behavioural indicator tables55.
Separate tables for intellectual functioning and adaptive 
behaviour functioning domains (conceptual, social, practical) 
are organized according to three age groups (early childhood, 
childhood/adolescence and adulthood) and four levels of se-
verity (mild, moderate, severe, profound). Behavioural indica-
tors describe those skills and abilities that would be typically 
observed within each of these categories and are expected to 
improve the reliability of the characterization of severity and to 
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improve public health data related to the burden of disorders of 
intellectual development.
Autism spectrum disorder in the ICD-11 incorporates both 
childhood autism and Asperger’s syndrome from the ICD-10 
under a single category characterized by social communication 
deficits and restricted, repetitive and inflexible patterns of be-
haviour, interests or activities. Guidelines for autism spectrum 
disorder have been substantially updated to reflect the current 
literature, including presentations throughout the lifespan. 
Qualifiers are provided for the extent of impairment in intel-
lectual functioning and functional language abilities to capture 
the full range of presentations of autism spectrum disorder in a 
more dimensional manner.
ADHD has replaced ICD-10 hyperkinetic disorders and has 
been moved to the grouping of neurodevelopmental disorders 
because of its developmental onset, characteristic disturbances 
in intellectual, motor and social functions, and common co- 
occurrence with other neurodevelopmental disorders. This 
move also addresses the conceptual weakness of viewing ADHD 
as more closely related to disruptive behaviour and dissocial 
disorders, given that individuals with ADHD are typically not 
intentionally disruptive.
ADHD can be characterized in the ICD-11 using qualifiers 
for predominantly inattentive, predominantly hyperactive- 
impulsive, or combined type, and is described across the lifespan.
Finally, chronic tic disorders, including Tourette syndrome, 
are classified in the ICD-11 chapter on diseases of the nervous 
system, but are cross-listed in the grouping of neurodevelop-
mental disorders because of their high co-occurrence (e.g., with 
ADHD) and typical onset during the developmental period.
Schizophrenia and other primary psychotic disorders
The ICD-11 grouping of schizophrenia and other primary 
psychotic disorders replaces the ICD-10 grouping of schizo-
phrenia, schizotypal and delusional disorders. The term “pri-
mary” indicates that psychotic processes are a core feature, in 
contrast to psychotic symptoms that may occur as an aspect of 
other forms of psychopathology (e.g., mood disorders)18.
In the ICD-11, schizophrenia symptoms have largely re-
mained unchanged from the ICD-10, though the importance 
of Schneiderian first-rank symptoms has been de-emphasized. 
The most significant change is the elimination of all subtypes of 
schizophrenia (e.g., paranoid, hebephrenic, catatonic), due to 
their lack of predictive validity or utility in treatment selection. 
In lieu of the subtypes, a set of dimensional descriptors has 
been introduced18. These include: positive symptoms (delu-
sions, hallucinations, disorganized thinking and behaviour, 
experiences of passivity and control); negative symptoms (con-
stricted, blunted or flat affect, alogia or paucity of speech, avo-
lition, anhedonia); depressive mood symptoms; manic mood 
symptoms; psychomotor symptoms (psychomotor agitation, 
psychomotor retardation, catatonic symptoms); and cogni-
tive symptoms (particularly deficits in speed of processing, 
attention/concentration, orientation, judgment, abstraction, 
verbal or visual learning, and working memory). These same 
symptom ratings can also be applied to other categories in the 
grouping (schizoaffective disorder, acute and transient psy-
chotic disorder, delusional disorder).
ICD-11 schizoaffective disorder still requires the near simul-
taneous presence of both the schizophrenia syndrome and a 
mood episode. The diagnosis is meant to reflect the current epi-
sode of illness and is not conceptualized as longitudinally stable.
ICD-11 acute and transient psychotic disorder is character-
ized by a sudden onset of positive psychotic symptoms that 
fluctuate rapidly in nature and intensity over a short period of 
time and persist no longer than three months. This corresponds 
only to the “polymorphic” form of acute psychotic disorder in 
the ICD-10, which is the most common presentation and one 
that is not indicative of schizophrenia56,57. Non-polymorphic 
subtypes of acute psychotic disorder in the ICD-10 have been 
eliminated and would instead be classified in the ICD-11 as 
“other primary psychotic disorder” . 
As in the ICD-10, schizotypal disorder is classified in this 
grouping and is not considered a personality disorder.
Mood disorders
Unlike in the ICD-10, ICD-11 mood episodes are not inde-
pendently diagnosable conditions, but rather their pattern over 
time is used as a basis for determining which mood disorder 
best fits the clinical presentation.
Mood disorders are subdivided into depressive disorders 
(which include single episode depressive disorder, recurrent 
depressive disorder, dysthymic disorder, and mixed depressive 
and anxiety disorder) and bipolar disorders (which include bi-
polar type I disorder, bipolar type II disorder, and cyclothymia). 
The ICD-11 subdivides ICD-10 bipolar affective disorder into 
bipolar type I and type II disorders. The separate ICD-10 sub-
grouping of persistent mood disorders, consisting of dysthymia 
and cyclothymia, has been eliminated58.
The diagnostic guidelines for depressive episode are one of 
the few places in the ICD-11 where a minimal symptom count 
is required. This is due to the longstanding research and clinical 
tradition of conceptualizing depression in this manner. A mini-
mum of five of ten symptoms is required rather than the four 
of nine possible symptoms stipulated in ICD-10, thus increas-
ing consistency with the DSM-5. The ICD-11 CDDG organize 
depressive symptoms into three clusters – affective, cognitive 
and neurovegetative – to assist clinicians in conceptualizing 
and recalling the full spectrum of depressive symptomatology. 
Fatigue is part of the neurovegetative symptom cluster but is no 
longer considered sufficient as an entry-level symptom; rather, 
either almost daily depressed mood or diminished interest in 
activities lasting at least two weeks is required. Hopelessness 
has been added as an additional cognitive symptom because of 
strong evidence of its predictive value for diagnoses of depres-
sive disorders59. The ICD-11 CDDG provide clear guidance on 
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the differentiation between culturally normative grief reactions 
and symptoms that warrant consideration as a depressive epi-
sode in the context of bereavement60.
For manic episodes, the ICD-11 requires the presence of the 
entry level symptom of increased activity or subjective experi-
ence of increased energy, in addition to euphoria, irritability 
or expansiveness. This is meant to guard against false positive 
cases that might be better characterized as normative fluctua-
tions in mood. ICD-11 hypomanic episodes are conceptualized 
as an attenuated form of manic episodes in the absence of 
significant functional impairment.
Mixed episodes are defined in the ICD-11 in a way that is 
conceptually equivalent to the ICD-10, based on evidence for 
the validity of this approach61. Guidance is provided regarding 
the typical contrapolar symptoms observed when either manic 
or depressive symptoms predominate. The presence of a mixed 
episode indicates a bipolar type I diagnosis.
The ICD-11 provides various qualifiers to describe the cur-
rent mood episode or remission status (i.e., in partial or in 
full remission). Depressive, manic and mixed episodes can be 
described as with or without psychotic symptoms. Current de-
pressive episodes in the context of depressive or bipolar disor-
ders can be further characterized by severity (mild, moderate or 
severe); by a melancholic features qualifier that bears a direct 
relationship with the concept of the somatic syndrome in ICD-
10; and by a qualifier to identify persistent episodes of more 
than two years’ duration. All mood episodes in the context of 
depressive or bipolar disorders can be further described using 
a prominent anxiety symptoms qualifier; a qualifier indicating 
the presence of panic attacks; and a qualifier to identify sea-
sonal pattern. A qualifier for rapid cycling is also available for 
bipolar disorder diagnoses.
The ICD-11 includes the category of mixed depressive and 
anxiety disorder because of its importance in primary care set-
tings62,63. This category has been moved from anxiety disorders 
in the ICD-10 to depressive disorders in the ICD-11 because of 
evidence of its overlap with mood symptomatology64.
Anxiety and fear-related disorders
The ICD-11 brings together disorders with anxiety or fear as 
the primary clinical feature in this new grouping65. Consistent 
with ICD-11’s lifespan approach, this grouping also includes 
separation anxiety disorder and selective mutism, which were 
placed among the childhood disorders in the ICD-10. The ICD-
10 distinction between phobic anxiety disorders and other 
anxiety disorders has been eliminated in the ICD-11 in favor 
of the more clinically useful method of characterizing each 
anxiety and fear-related disorder according to its focus of ap-
prehension66; that is, the stimulus reported by the individual 
as triggering his or her anxiety, excessive physiological arousal 
and maladaptive behavioural responses. Generalized anxiety 
disorder (GAD) is characterized by general apprehensiveness 
or worry that is not restricted to any particular stimulus.
In the ICD-11, GAD has a more elaborated set of essential 
features, reflecting advances in the understanding of its unique 
phenomenology; in particular, worry is added to general appre-
hension as a core feature of the disorder. Contrary to ICD-10, 
the ICD-11 CDDG specify that GAD can co-occur with depres-
sive disorders as long as symptoms are present independent of 
mood episodes. Similarly, other ICD-10 hierarchical exclusion 
rules (e.g., GAD cannot be diagnosed together with phobic 
anxiety disorder or obsessive-compulsive disorder) are also 
eliminated, due to the better delineation of disorder phenome-
nology in the ICD-11 and the evidence that those rules interfere 
with detection and treatment of conditions requiring separate 
specific clinical attention.
In the ICD-11, agoraphobia is conceptualized as marked 
and excessive fear or anxiety that occurs in, or in anticipation 
of, multiple situations where escape might be difficult or help 
not available. The focus of apprehension is fear of specific nega-
tive outcomes that would be incapacitating or embarrassing 
in those situations, which is distinct from the narrower concept 
in the ICD-10 of fear of open spaces and related situations, 
such as crowds, where an escape to a safe place may be diffi-
cult.
Panic disorder is defined in the ICD-11 by recurrent unex-
pected panic attacks that are not restricted to particular stimuli 
or situations. The ICD-11 CDDG indicate that panic attacks 
which occur entirely in response to exposure or anticipation of 
the feared stimulus in a given disorder (e.g., public speaking in 
social anxiety disorder) do not warrant an additional diagnosis 
of panic disorder. Rather, a “with panic attacks” qualifier can be 
applied to the other anxiety disorder diagnosis. The “with panic 
attacks” qualifier can also be applied in the context of other 
disorders where anxiety is a prominent though not defining 
feature (e.g., in some individuals during a depressive episode).
ICD-11 social anxiety disorder, defined on the basis of fear of 
negative evaluation by others, replaces ICD-10 social phobias.
The ICD-11 CDDG specifically describe separation anxiety 
disorder in adults, where it is most commonly focused on a 
romantic partner or a child.
Obsessive-compulsive and related disorders
The introduction of the OCRD grouping in the ICD-11 rep-
resents a significant departure from the ICD-10. The ration-
ale for creating an OCRD grouping distinct from anxiety and 
fear-related disorders, despite phenomenological overlap, is 
based on the clinical utility of collating disorders with shared 
symptoms of repetitive unwanted thoughts and related repeti-
tive behaviours as the primary clinical feature. The diagnostic 
coherence of this grouping comes from emerging evidence of 
the shared validators among included disorders from imaging, 
genetic and neurochemical studies35.
ICD-11 OCRD include obsessive-compulsive disorder, 
body dysmorphic disorder, olfactory reference disorder, hypo-
chondriasis (illness anxiety disorder) and hoarding disorder. 
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Equivalent categories that exist in the ICD-10 are located in 
disparate groupings. Also included in OCRD is a subgroup-
ing of body-focused repetitive behaviour disorders that in-
cludes trichotillomania (hair-pulling disorder) and excoriation 
(skin-picking) disorder, both sharing the core feature of repeti-
tive behaviour without the cognitive aspect of other OCRDs. 
Tourette syndrome, a disease of the nervous system in ICD-11, 
is cross-listed in the OCRD grouping because of its frequent 
co-occurrence with obsessive-compulsive disorder.
The ICD-11 retains the core features of ICD-10 obsessive-
compulsive disorder, that is, persistent obsessions and/or 
compulsions, but with some important revisions. The ICD-11 
broadens the concept of obsessions beyond intrusive thoughts 
to include unwanted images and urges/impulses. Moreover, 
the concept of compulsions is expanded to include covert (e.g., 
repeated counting) as well as overt repetitive behaviours.
Although anxiety is the most common affective experience 
associated with obsessions, the ICD-11 explicitly mentions 
other phenomena reported by patients, such as disgust, shame, 
a sense of “incompleteness” , or uneasiness that things do not 
look or feel “right”. ICD-10 subtypes of OCD are eliminated, 
because the majority of patients report both obsessions and 
compulsions, and because they lack predictive validity for 
treatment response. The ICD-10 prohibition against diagnosing 
obsessive-compulsive disorder along with depressive disorders 
is removed in the ICD-11, reflecting the high rate of co-occur-
rence of these disorders and the need for distinct treatments.
Hypochondriasis (health anxiety disorder) is placed in OCRD 
rather than among anxiety and fear-related disorders, even 
though health preoccupations are often associated with anxiety 
and fear, because of shared phenomenology and patterns of 
familial aggregation with OCRD67. However, hypochondriasis 
(health anxiety disorder) is cross-listed in the anxiety and fear-
related disorders grouping, in recognition of some phenomeno-
logical overlap.
Body dysmorphic disorder, olfactory reference disorder, and 
hoarding disorder are new categories in ICD-11 that have been 
included in the OCRD grouping.
In OCRDs that have a cognitive component, beliefs may be 
held with such intensity or fixity that they appear to be delu-
sional. When these fixed beliefs are entirely consistent with the 
phenomenology of the OCRD, in the absence of other psychot-
ic symptoms, the qualifier “with poor to absent insight” should 
be used, and a diagnosis of delusional disorder should not be 
assigned. This is intended to help guard against inappropriate 
treatment for psychosis among individuals with OCRDs35.
Disorders specifically associated with stress
The ICD-11 grouping of disorders specifically associated 
with stress replaces ICD-10 reactions to severe stress and ad-
justment disorders, to emphasize that these disorders share 
the necessary (but not sufficient) etiologic requirement for 
exposure to a stressful event, as well as to distinguish included 
disorders from the various other mental disorders that arise 
as a reaction to stressors (e.g., depressive disorders)41. ICD-10 
reactive attachment disorder of childhood and disinhibited at-
tachment disorder of childhood are reclassified to this grouping 
owing to the lifespan approach of the ICD-11 and in recognition 
of the specific attachment-related stressors inherent to these 
disorders. The ICD-11 includes several important conceptual 
updates to the ICD-10 as well as the introduction of complex 
PTSD and prolonged grief disorder, which have no equivalent 
in the ICD-10.
PTSD is defined by three features that should be present 
in all cases and must cause significant impairment. They are: 
re-experiencing the traumatic event in the present; deliberate 
avoidance of reminders likely to produce re-experiencing; and 
persistent perceptions of heightened current threat. The inclu-
sion of the requirement for re-experiencing the cognitive, affec-
tive or physiological aspects of the trauma in the here and now 
rather than just remembering the event is expected to address 
the low diagnostic threshold for PTSD in ICD-1042.
Adjustment disorder in the ICD-11 is defined on the basis of 
the core feature of preoccupation with a life stressor or its con-
sequences, while in the ICD-10 the disorder was diagnosed if 
symptoms occurring in response to a life stressor did not meet 
definitional requirements of another disorder.
Finally, acute stress reaction is no longer considered to be a 
mental disorder in the ICD-11, but instead is understood to be 
a normal reaction to an extreme stressor. Thus, it is classified 
in the ICD-11 chapter on “factors influencing health status or 
contact with health services”, but cross-listed in the grouping 
of disorders specifically associated with stress to assist with 
differential diagnosis.
Dissociative disorders
The ICD-11 dissociative disorders grouping corresponds 
to ICD-10 dissociative (conversion) disorders, but has been 
significantly reorganized and simplified, to reflect recent em-
pirical findings and to enhance clinical utility. Reference to the 
term “conversion” is eliminated from the grouping title68. ICD-
11 dissociative neurological symptom disorder is conceptually 
consistent with ICD-10 dissociative disorders of movement 
and sensation, but is presented as a single disorder with twelve 
subtypes defined on the basis of the predominant neurologi-
cal symptom (e.g., visual disturbance, non-epileptic seizures, 
speech disturbance, paralysis or weakness). ICD-11 disso-
ciative amnesia includes a qualifier to indicate whether dis-
sociative fugue is present, a phenomenon that is classified as a 
separate disorder in ICD-10.
The ICD-11 divides ICD-10 possession trance disorder into 
the separate diagnoses of trance disorder and possession trance 
disorder. The separation reflects the distinctive feature in pos-
session trance disorder wherein the customary sense of personal 
identity is replaced by an external “possessing” identity attrib-
uted to the influence of a spirit, power, deity or other spiritual 
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entity. In addition, a greater range of more complex behaviours 
may be exhibited in possession trance disorder, while trance 
disorder typically involves the repetition of a small repertoire of 
simpler behaviours.
ICD-11 dissociative identity disorder corresponds to the con-
cept of ICD-10 multiple personality disorder and is renamed to 
be consistent with currently used nomenclature in clinical and 
research contexts. The ICD-11 also introduces partial dissocia-
tive identity disorder, reflecting the fact that the preponderance 
of ICD-10 unspecified dissociative disorders is accounted for by 
presentations in which non-dominant personality states do not 
recurrently take executive control of the individual’s conscious-
ness and functioning.
Depersonalization and derealization disorder, located in the 
other neurotic disorders grouping in the ICD-10, is moved to 
the dissociative disorders grouping in the ICD-11.
Feeding and eating disorders
The ICD-11 grouping of feeding and eating disorders inte-
grates ICD-10 eating disorders and feeding disorders of child-
hood, in recognition of the interconnectedness of these disorders 
across the lifespan, as well as reflecting the evidence that these 
disorders can apply to individuals across a broader range of 
ages45,47.
The ICD-11 provides updated conceptualizations of anorex-
ia nervosa and bulimia nervosa to incorporate recent evidence, 
which eliminates the need for ICD-10 “atypical” categories. It 
also includes the new entities of binge eating disorder, which 
is introduced based on empirical support for its validity and 
clinical utility, and ARFID, which expands upon ICD-10 feed-
ing disorder of infancy and childhood.
Anorexia nervosa in the ICD-11 eliminates the ICD-10 re-
quirement for the presence of a widespread endocrine disor-
der, because evidence suggests that this does not occur in all 
cases and, even when present, is a consequence of low body 
weight rather than a distinct defining feature of the disorder. 
Furthermore, cases without endocrine disorder were largely 
responsible for atypical anorexia diagnoses. The threshold for 
low body weight in ICD-11 is raised from 17.5 kg/m2 to 18 kg/
m2, but the guidelines accommodate situations in which the 
body mass index may not adequately reflect a worsening clini-
cal picture (e.g., precipitous weight loss in the context of other 
features of the disorder). Anorexia nervosa does not require 
“fat phobia” as in the ICD-10, to allow for the full spectrum of 
culturally diverse rationales for food refusal and expressions of 
body preoccupation.
Qualifiers are provided to characterize the severity of un-
derweight status, given that extremely low body mass index is 
associated with greater risk of morbidity and mortality. A quali-
fier describing the pattern of associated behaviours is included 
(i.e., restricting pattern, binge-purge pattern).
Bulimia nervosa in the ICD-11 can be diagnosed regard-
less of the current weight of the individual, as long as the body 
mass index is not so low as to meet definitional requirements 
for anorexia nervosa. In lieu of specific minimal binge frequen-
cies that are, in fact, not supported by evidence, the ICD-11 
provides more flexible guidance. A bulimia nervosa diagnosis 
does not require “objective” binges and can be diagnosed on 
the basis of “subjective” binges, in which the individual eats 
more or differently than usual and experiences a loss of control 
over eating accompanied by distress, regardless of the amount 
of food actually eaten. This change is expected to reduce the 
number of unspecified feeding and eating disorder diagnoses.
Elimination disorders
The term “non-organic” is removed from the ICD-11 elimi-
nation disorders, which include enuresis and encopresis. These 
disorders are differentiated from those that can be better ac-
counted for by another health condition or the physiological 
effects of a substance.
Disorders of bodily distress and bodily experience
ICD-11 disorders of bodily distress and bodily experience en-
compass two disorders: bodily distress disorder and body integ-
rity dysphoria. ICD-11 bodily distress disorder replaces ICD-10 
somatoform disorders and also includes the concept of ICD-10 
neurasthenia. ICD-10 hypochondriasis is not included and in-
stead is reassigned to the OCRD grouping.
Bodily distress disorder is characterized by the presence of 
bodily symptoms that are distressing to the individual and an ex-
cessive attention directed toward the symptoms, which may be 
manifest by repeated contact with health care providers69. The 
disorder is conceptualized as existing on a continuum of sever-
ity and can be qualified accordingly (mild, moderate or severe) 
depending on the impact on functioning. Importantly, bodily 
distress disorder is defined according to the presence of essential 
features, such as distress and excessive thoughts and behaviours, 
rather than on the basis of absent medical explanations for both-
ersome symptoms, as in ICD-10 somatoform disorders.
ICD-11 body integrity dysphoria is a newly introduced diag-
nosis that is incorporated into this grouping48.
Disorders due to substance use and addictive behaviours
The ICD-11 grouping of disorders due to substance use and 
addictive behaviours encompasses disorders that develop as a 
result of the use of psychoactive substances, including medi-
cations, and disorders due to addictive behaviours that de-
velop as a result of specific repetitive rewarding and reinforcing 
behaviours.
The organization of ICD-11 disorders due to substance use 
is consistent with the approach in the ICD-10, whereby clini-
cal syndromes are classified according to substance classes70. 
World Psychiatry 18:1 - February 2019 15
However, the list of substances in the ICD-11 is expanded to 
reflect current availability and contemporary use patterns of 
substances. Each substance or substance class can be asso-
ciated with mutually exclusive primary clinical syndromes: 
single episode of harmful substance use or harmful pattern of 
substance use, which represents a refinement of ICD-10 harm-
ful use; and substance dependence. Substance intoxication and 
substance withdrawal can be diagnosed either together with 
primary clinical syndromes or independently as a reason for 
delivery of health services when the pattern of use or possibility 
of dependence is unknown.
Given the extremely high global disease burden of disor-
ders due to substance use, the grouping has been revised to 
optimally enable the capture of health information that will be 
useful in multiple contexts, support accurate monitoring and 
reporting, and inform both prevention and treatment70. The 
addition of ICD-11 single episode of harmful substance use 
provides an opportunity for early intervention and prevention 
of escalation of use and harm, whereas the diagnoses of harm-
ful pattern of substance use and substance dependence suggest 
the need for increasingly intensive interventions.
The ICD-11 expands the concept of harm to health due to 
substance use to comprise harm to the health of other people, 
which can include either physical harm (e.g., due to driving 
while intoxicated) or psychological harm (e.g., development of 
PTSD following an automobile accident).
The ICD-11 includes substance-induced mental disorders 
as syndromes characterized by clinically significant mental or 
behavioural symptoms that are similar to those of other men-
tal disorders but that develop due to psychoactive substance 
use. Substance-induced disorders can be related to substance 
intoxication or substance withdrawal, but the intensity or du-
ration of symptoms are substantially in excess of those char-
acteristic of intoxication or withdrawal due to the specified 
substances.
The ICD-11 also includes categories of hazardous substance 
use, which are not classified as mental disorders but rather are 
situated in the chapter on “factors influencing health status or 
contact with health services” . These categories may be used 
when a pattern of substance use increases the risk of harmful 
physical or mental health consequences to the user or to oth-
ers to an extent that warrants attention and advice from health 
professionals, but no overt harm has yet occurred. They are 
meant to signal opportunities for early and brief interventions, 
particularly in primary care settings.
ICD-11 disorders due to addictive behaviours include two 
diagnostic categories: gambling disorder (pathological gam-
bling in ICD-10) and gaming disorder, which is newly intro-
duced49. In ICD-10, pathological gambling was classified as a 
habit and impulse disorder. However, recent evidence points 
to important phenomenological similarities between disor-
ders due to addictive behaviours and substance use disorders, 
including their higher co-occurrence as well as the common 
feature of being initially pleasurable followed by progression 
to loss of hedonic value and need for increased use. Moreover, 
disorders due to substance use and disorders due to addictive 
behaviours appear to share similar neurobiology, especially 
activation and neuroadaptation within the reward and motiva-
tion neural circuits71.
Impulse control disorders
ICD-11 impulse control disorders are characterized by the 
repeated failure to resist a strong impulse, drive or urge to per-
form an act that is rewarding to the person, at least in the short- 
term, despite longer-term harm either to the individual or to oth-
ers.
This grouping includes pyromania and kleptomania, which 
are classified in the ICD-10 under habit and impulse disorders.
The ICD-11 introduces intermittent explosive disorder and 
reclassifies ICD-10 excessive sexual drive to this grouping as 
ICD-11 compulsive sexual behaviour disorder50,72,73.
Disruptive behaviour and dissocial disorders
The ICD-11 grouping of disruptive behaviour and dissocial 
disorders replaces ICD-10 conduct disorders. The new term 
better reflects the full range of severity of behaviours and phe-
nomenology observed in the two conditions included in this 
grouping: oppositional defiant disorder and conduct-dissocial 
disorder. An important change introduced in the ICD-11 is that 
both disorders can be diagnosed across the lifespan, whereas the 
ICD-10 construes them as disorders of childhood. Additionally, 
the ICD-11 introduces qualifiers that characterize subtypes of 
disruptive behaviour and dissocial disorders intended to im-
prove clinical utility (e.g., prognostically).
ICD-11 oppositional defiant disorder is conceptually simi-
lar to its ICD-10 equivalent category. However, a “with chronic 
irritability and anger” qualifier is provided to characterize 
those presentations of the disorder with prevailing, persistent 
irritable mood or anger. This presentation is recognized to 
significantly increase the risk for subsequent depression and 
anxiety. The ICD-11 conceptualization of this presentation 
as a form of oppositional defiant disorder is concordant with 
current evidence and diverges from the DSM-5 approach of 
introducing a new disorder, disruptive mood dysregulation 
disorder74-76.
ICD-11 conduct disorder consolidates the three separate 
conduct disorder diagnoses classified in ICD-10 (i.e., confined 
to the family context, unsocialized, socialized). The ICD-11 ac-
knowledges that disruptive behaviour and dissocial disorders 
are frequently associated with problematic psychosocial envi-
ronments and psychosocial risk factors, such as peer rejection, 
deviant peer group influences, and parental mental disorder. 
A clinically meaningful distinction between childhood and 
adolescent onset of the disorder can be indicated with a quali-
fier, based on the evidence that earlier onset is associated with 
more severe pathology and a poorer course of the disorder.
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A qualifier to indicate limited prosocial emotions can be 
assigned to both disruptive behaviour and dissocial dis orders. 
In the context of an oppositional defiant disorder diagnosis, 
this presentation is associated with a more stable and extreme 
pattern of oppositional behaviours. In the context of conduct-
dissocial disorder, it is associated with a tendency towards 
a more severe, aggressive and stable pattern of antisocial be-
haviour.
Personality disorders
Problems with the ICD-10 classification of ten specific per-
sonality disorders included substantial underdiagnosis rela-
tive to their prevalence among individuals with other mental 
disorders, the fact that only two of the specific personality dis-
orders (emotionally unstable personality disorder, borderline 
type, and dissocial personality disorder) were recorded with 
any frequency in publicly available databases, and that rates 
of co-occurrence were extremely high, with most individuals 
with severe disorders meeting the requirements for multiple 
personality disorders16,17.
The ICD-11 CDDG ask the clinician to first determine wheth-
er the individual’s clinical presentation meets the general diag-
nostic requirements for personality disorder. The clinician then 
determines whether a diagnosis of mild, moderate or severe 
personality disorder is appropriate, based on: a) the degree 
and pervasiveness of disturbances in functioning of aspects 
of the self (e.g., stability and coherence of identity, self-worth, 
accuracy of self-view, capacity for self-direction); b) the degree 
and pervasiveness of interpersonal dysfunction (e.g., under-
standing others’ perspectives, developing and maintaining 
close relationships, managing conflict) across various contexts 
and relationships; c) the pervasiveness, severity and chronicity 
of emotional, cognitive and behavioural manifestations of per-
sonality dysfunction; and d) the extent to which these patterns 
are associated with distress or psychosocial impairment.
Personality disorders are then further described by indi-
cating the presence of characteristic maladaptive personality 
traits. Five trait domains are included: negative affectivity (the 
tendency to experience a broad range of negative emotions); 
detachment (the tendency to maintain social and interpersonal 
distance from others); dissociality (disregard for the rights and 
feelings of others, encompassing both self-centeredness and 
lack of empathy); disinhibition (the tendency to act impulsively 
in response to immediate internal or environmental stimuli 
without consideration of longer-term consequences); and 
anankastia (a narrow focus on one’s rigid standard of perfec-
tion and of right and wrong and on controlling one’s own and 
others’ behaviour to ensure conformity to those standards). 
As many of these trait domains may be assigned as part of the 
diagnosis as are judged to be prominent and contributing to the 
personality disorder and its severity.
In addition, an optional qualifier is provided for “border-
line pattern” . This qualifier is intended to ensure continuity of 
care during the transition from the ICD-10 to the ICD-11 and 
may enhance clinical utility by facilitating the identification 
of individuals who may respond to certain psychotherapeutic 
treatments. Additional research will be needed to determine 
whether it provides information that is distinct from that pro-
vided by the trait domains.
The ICD-11 also includes a category for personality diffi-
culty, which is not considered a mental disorder, but rather is 
listed in the grouping of problems associated with interper-
sonal interactions in the chapter on “factors influencing health 
status or contact with health services” . Personality difficulty 
refers to pronounced personality characteristics that may affect 
treatment or provision of health services but do not rise to the 
level of severity to warrant a diagnosis of personality disorder.
Paraphilic disorders
The ICD-11 grouping of paraphilic disorders replaces the ICD-
10 grouping of disorders of sexual preference, consistent with 
contemporary terminology used in research and clinical con-
texts. The core feature of paraphilic disorders is that they involve 
sexual arousal patterns that focus on non-consenting others77.
ICD-11 paraphilic disorders include exhibitionistic disorder, 
voy euristic disorder, and pedophilic disorder. Newly introduced 
categories are coercive sexual sadism disorder, frot teuristic dis-
order, and other paraphilic disorder involving non-consenting 
individuals. A new category of other paraphilic disorder in-
volving solitary behaviour or consenting individuals is also in-
cluded, which can be assigned when sexual thoughts, fantasies, 
urges or behaviours are associated with substantial distress 
(but not as a consequence of rejection or feared rejection of the 
arousal pattern by others) or confer direct risk of injury or death 
(e.g., asphyxophilia).
The ICD-11 distinguishes between conditions that are rel-
evant to public health and clinical psychopathology and those 
that merely reflect private behaviour, and for this reason the 
ICD-10 categories of sadomasochism, fetishism, and fetishistic 
transvestism have been eliminated26.
Factitious disorders
The ICD-11 introduces a new grouping of factitious disor-
ders that includes factitious disorder imposed on the self and 
factitious disorder imposed on another. This grouping is con-
ceptually equivalent to the ICD-10 diagnosis of intentional pro-
duction or feigning of symptoms or disabilities, either physical 
or psychological (factitious disorder), but extended to include 
the clinical situation where an individual feigns, falsifies, or 
intentionally induces or aggravates medical, psychological or 
behavioural signs and symptoms in another individual (usu-
ally a child).
The behaviours are not solely motivated by obvious external 
rewards or incentives, and are distinguished on this basis from 
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malingering, which is not classified as a mental, behavioural or 
neurodevelopmental disorder, but rather appears in the chap-
ter on “factors influencing health status or contact with health 
services” .
Neurocognitive disorders
ICD-11 neurocognitive disorders are acquired conditions 
characterized by primary clinical deficits in cognitive func-
tioning, and include most conditions that are classified among 
ICD-10 organic, including symptomatic, mental disorders. 
Thus, the grouping includes delirium, mild neurocognitive 
disorder (called mild cognitive disorder in ICD-10), amnestic 
disorder, and dementia. Delirium and amnestic disorder can 
be classified as due to a medical condition classified elsewhere, 
due to a substance or a medication, or due to multiple etiologi-
cal factors. Dementia may be classified as mild, moderate or 
severe.
The syndromal characteristics of dementia associated with 
different etiologies (e.g., dementia due to Alzheimer disease, 
dementia due to human immunodeficiency virus) are classi-
fied and described within the chapter on mental, behavioural 
and neurodevelopmental disorders, whereas the underlying 
etiologies are classified using categories from the chapter on 
dis eases of the nervous system or other sections of the ICD, 
as appropriate78. Mild neurocognitive disorder can also be 
identified in conjunction with an etiological diagnosis, reflect-
ing improved detection methods for early cognitive decline, 
which represents an opportunity to provide treatment in order 
to delay disease progression. The ICD-11 therefore clearly rec-
ognizes the cognitive, behavioural and emotional components 
of neurocognitive disorders as well as their underlying causes.
CONCLUSIONS
The development of the ICD-11 CDDG for mental, behav-
ioural and neurodevelopmental disorders and their underlying 
statistical classification represents the first major revision of the 
world’s foremost classification of mental disorders in nearly 
30 years. It has involved an unprecedented level and range of 
global, multilingual and multidisciplinary participation. Sub-
stantial changes have been made to increase scientific validity 
in the light of current evidence and to enhance clinical utility 
and global applicability based on a systematic program of field 
testing.
Now, both the version of the ICD-11 chapter to be used by 
WHO member states for health statistics and the CDDG for use in 
clinical settings by mental health professionals are substantively 
complete. In order for the ICD-11 to achieve its potential in the 
world, the WHO’s focus will shift to working with member states 
and with health professionals on implementation and training.
The implementation of a new classification system involves 
the interaction of the classification with each country’s laws, 
policies, health systems and information infrastructure. Multi-
ple modalities must be developed for training a vast array of 
international health professionals. We look forward to continu-
ing our very productive collaboration with the WPA and to 
working with member states, academic centers, professional 
and scientific organizations and with civil societies in this next 
phase of work.
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